Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

Westwicke Blog

The ICR Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

4 Benefits of Conducting a Perception Audit

Posted on October 20th, 2021. Posted by

Full,Length,Portrait,Of,Business,Team,Stand,Near,The,Window

Do you know how the investment community views your company, including your products, leadership team, business strategy, and financial performance? Asking the tough questions and opening your company up to potential negative feedback can be a scary prospect, but it’s well worth it. By conducting a perception audit — an independent investigation into investor and analyst impressions of a company — your company can realize the following benefits. 

Continue Reading

The 10 Must-Dos for an Effective Biotech Investor Plan

Posted on September 7th, 2021. Posted by

10 Biotech Must Dos

Why would anyone invest in in a biotech or biopharma company? After all, most are development-stage companies based on complicated science that consume cash voraciously, have no revenue or earnings, and need to sell a dream that could be years away from commercialization.

The risks are enormous. Yet they attract investors because the payoff can be huge. Here are the 10 must-do items that all public biotech companies should address in an effective IR program in order to attract the right investors.

Continue Reading

What is an 8K and how do you read one?

Posted on July 8th, 2021. Posted by

what-is-an-8k-and-how-do-you-read-one

What is an 8-K?

Form 8-K, also known as an 8K, is a form that is filed by public companies to notify their shareholders and the Securities and Exchange Commission (SEC) when an unscheduled material event takes place. In other words, it’s an announcement that a major event or corporate change that may be of interest to investors, has occurred. Form 8K is known as a “current report” and is filed in addition to an annual report on Form 10-K and a quarterly report on Form 10-Q.

Continue Reading

How to Host an Effective R&D Day: 5 Key Elements

Posted on June 9th, 2021. Posted by

Hosting an R&D Event

A well-planned and executed research and development (R&D) day can reinforce a company’s message, heighten a company’s visibility, and allow a management team to highlight their investment thesis. It can be an effective and efficient investor relations tool if done correctly.

Continue Reading

Quiet Periods FAQ: What You Need to Know

Posted on April 22nd, 2021. Posted by

Quiet Periods

Unlike quiet periods following an IPO, which are closely regulated by the Securities and Exchange Commission (SEC), end-of-quarter quiet periods are more loosely defined and not strictly regulated.

Continue Reading

Top 10 Benefits Of Non-Deal Road Shows

Posted on April 8th, 2021. Posted by

Top 10 Benefits of Non-Deal Road Shows

Right after you report earnings is the ideal time to get out on the road and tell your story to the Street. Sell-side analysts are incentivized to market with management teams, so they are always willing to sponsor a non-deal road show (NDRS).

Continue Reading

The Evolution of the Retail Investor and Sentiment Trading

Posted on March 18th, 2021. Posted by

Retail Investors

In 2018, we wrote a piece on best practices to manage and communicate with the growing retail investor community. While the basic tenants of those recommendations hold today, the retail investor has fundamentally changed over the last couple of years.

Continue Reading

Form 8-K or Press Release: Know the Difference When You Disclose News

Posted on March 4th, 2021. Posted by

Form 8-k or Press Release

One of our clients, a recently public diagnostics company, settled an ongoing royalty dispute with a major pharmaceutical company. The settlement amount was significantly lower than what our client had accrued, resulting in nearly $750 thousand upside to their P&L in the upcoming quarter.

Continue Reading

Our Most-Read Investor Relations Posts of 2020

Posted on February 23rd, 2021. Posted by

Top 2020 Westwicke Content

No one would argue that 2020 was unique and challenging for almost every industry, including healthcare. The year forced both public and private companies to reconsider many aspects of how they do business and communicate with the investment community. As we all adapted and learned, our Westwicke blog covered a variety of investor relations topics, both pandemic related and not. Below are some of the most popular blog posts we published this year.

Continue Reading

How to Write Your Annual Letter to Shareholders

Posted on January 19th, 2021. Posted by

Writing Your Annual Letter to Shareholders

Warren Buffet makes the news each year for his letter to Berkshire Hathaway shareholders. By employing his uniquely wry and contrarian style and covering many topics that have little direct bearing on Berkshire’s results or prospects, Buffet has taken one of the staple obligations of a public company CEO, and turned it into something much larger — a kind of State of the Union from the desk of one of our most important business leaders.

Continue Reading

1 2 3 19

Preparing for an investor meeting?

Download our checklist of 6 questions investors will ask to make a decision about your company.

Our Locations